Who owns LEXEO THERAPEUTICS INC?
- Ticker: LXEO
- CUSIP Number: 52886x107
Tip: Access positions for across all investors
Analyze quarterly positions in Lexeo Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lexeo Therapeutics stock
Who bought or sold LEXEO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Eventide Asset Management | 3.4M | $53M | 12% | Mar 2024 |
|
| Henderson Group | 2.5M | $40M | 9% | Mar 2024 |
|
| Citadel Advisors | 2.5M | $39M | 20% | Mar 2024 |
|
| Omega Fund Management | 2.2M | $29M | 100% | Dec 2023 |
|
| Adage Capital Partners GP | 1.3M | $21M | 100% | Mar 2024 |
|
| Braidwell | 1.3M | $21M | 100% | Mar 2024 |
|
| Artal Group | 802k | $13M | 33% | Mar 2024 |
|
| Blackstone Group | 696k | $11M | 0% | Mar 2024 |
|
| BlackRock | 663k | $10M | 100% | Mar 2024 |
|
| RA Capital Management | 661k | $10M | 100% | Mar 2024 |
|
| Millennium Management | 594k | $8.7M | 1246% | Mar 2024 |
|
| Vanguard Group | 482k | $7.6M | 16% | Mar 2024 |
|
| Laurion Capital Management | 454k | $7.1M | 78% | Mar 2024 |
|
| Geode Capital Management | 198k | $3.1M | 100% | Mar 2024 |
|
| Cornell University | 126k | $2.0M | 100% | Mar 2024 |
|
| Bank Of Montreal | 111k | $1.8M | 100% | Mar 2024 |
|
| Northern Trust | 82k | $1.3M | 100% | Mar 2024 |
|
| Verition Fund Management | 61k | $954k | 100% | Mar 2024 |
|
| Citigroup | 49k | $771k | -46% | Mar 2024 |
|
| Jane Street | 40k | $626k | 2% | Mar 2024 |
|
| Bank of New York Mellon | 28k | $444k | 101% | Mar 2024 |
|
| Charles Schwab Investment Management | 27k | $429k | 100% | Mar 2024 |
|
| Goldman Sachs Group | 24k | $369k | 100% | Mar 2024 |
|
| Barclays | 23k | $359k | 48% | Mar 2024 |
|
| Morgan Stanley | 14k | $219k | 100% | Mar 2024 |
|
| Nuveen Asset Management | 14k | $211k | 100% | Mar 2024 |
|
| Woodline Partners | 12k | $189k | 100% | Mar 2024 |
|
| Susquehanna International | 12k | $189k | 100% | Mar 2024 |
|
| UBS Group | 10k | $163k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 9.7k | $153k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 6.0k | $93k | 5215% | Mar 2024 |
|
| Bank of America Corporation | 5.3k | $83k | -35% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 4.8k | $75k | 100% | Mar 2024 |
|
| New York State Common Retirement Fund | 4.1k | $64k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 3.4k | $53k | 4579% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 1.8k | $28k | 100% | Mar 2024 |
|
| California State Teachers Retirement System | 1.0k | $16k | 100% | Mar 2024 |
|
| Summit Investment Advisors | 1.0k | $16k | 100% | Mar 2024 |
|
| Legal & General Group | 863.00 | $14k | -94% | Mar 2024 |
|
| Amalgamated Bank | 623.00 | $10k | 100% | Mar 2024 |
|
| Tower Research Capital | 507.00 | $8.0k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 351.00 | $6.0k | 100% | Mar 2024 |
|
| FMR | 13.00 | $203.999900 | 100% | Mar 2024 |
|
Who sold out of Lexeo Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Point72 Middle East FZE | Dec 2023 | 29k | $384k |
| Cubist Systematic Strategies | Dec 2023 | 26k | $346k |
| Steward Partners Investment Advisory | Dec 2023 | 323.00 | $4.3k |